Citation
Vellozzi, Claudia, et al. "Adverse Events Following Influenza a (H1N1) 2009 Monovalent Vaccines Reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010." Vaccine, vol. 28, no. 45, 2010, pp. 7248-55.
Vellozzi C, Broder KR, Haber P, et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010;28(45):7248-55.
Vellozzi, C., Broder, K. R., Haber, P., Guh, A., Nguyen, M., Cano, M., Lewis, P., McNeil, M. M., Bryant, M., Singleton, J., Martin, D., & DeStefano, F. (2010). Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine, 28(45), 7248-55. https://doi.org/10.1016/j.vaccine.2010.09.021
Vellozzi C, et al. Adverse Events Following Influenza a (H1N1) 2009 Monovalent Vaccines Reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010 Oct 21;28(45):7248-55. PubMed PMID: 20850534.
TY - JOUR
T1 - Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
AU - Vellozzi,Claudia,
AU - Broder,Karen R,
AU - Haber,Penina,
AU - Guh,Alice,
AU - Nguyen,Michael,
AU - Cano,Maria,
AU - Lewis,Paige,
AU - McNeil,Michael M,
AU - Bryant,Marthe,
AU - Singleton,James,
AU - Martin,David,
AU - DeStefano,Frank,
Y1 - 2010/09/16/
PY - 2010/08/24/received
PY - 2010/08/31/revised
PY - 2010/09/09/accepted
PY - 2010/9/21/entrez
PY - 2010/9/21/pubmed
PY - 2011/1/25/medline
SP - 7248
EP - 55
JF - Vaccine
JO - Vaccine
VL - 28
IS - 45
N2 - The United States (US) influenza A (H1N1) 2009 monovalent (2009-H1N1) vaccination program began in October 2009. Reports to the vaccine adverse event reporting system (VAERS), a US spontaneous reporting system, were reviewed to identify potential rare events or unusual adverse event (AE) patterns after 2009-H1N1 vaccination. The adverse event profile after 2009-H1N1 vaccine in VAERS (∼10,000 reports) was consistent with that of seasonal influenza vaccines, although the reporting rate was higher after 2009-H1N1 than seasonal influenza vaccines, this may be, at least in part, a reflection of stimulated reporting. Death, Guillain-Barré syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered).
SN - 1873-2518
UR - https://www.unboundmedicine.com/medline/citation/20850534/Adverse_events_following_influenza_A__H1N1__2009_monovalent_vaccines_reported_to_the_Vaccine_Adverse_Event_Reporting_System_United_States_October_1_2009_January_31_2010_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(10)01331-9
DB - PRIME
DP - Unbound Medicine
ER -